Varna M - Search Results

1

Development and Characterization of Innovative Multidrug Nanoformulation for Cardiac Therapy.

Gendron A, Domenichini S, Zanna S, Gobeaux F, Piesse C, Desmaële D, Varna M. Gendron A, et al. Among authors: varna m. Materials (Basel). 2023 Feb 22;16(5):1812. doi: 10.3390/ma16051812. Materials (Basel). 2023. PMID: 36902927 Free PMC article.

2

Assessment of Squalene-Adenosine Nanoparticles in Two Rodent Models of Cardiac Ischemia-Reperfusion.

Brusini R, Tran NLL, Cailleau C, Domergue V, Nicolas V, Dormont F, Calet S, Cajot C, Jouran A, Lepetre-Mouelhi S, Laloy J, Couvreur P, Varna M. Brusini R, et al. Among authors: varna m. Pharmaceutics. 2023 Jun 21;15(7):1790. doi: 10.3390/pharmaceutics15071790. Pharmaceutics. 2023. PMID: 37513977 Free PMC article.

3

Advances in Natural and Bio-Inspired Nanoparticles for the Treatment of Cardiovascular Diseases.

Varna M, Calin M, Gebeshuber IC. Varna M, et al. Nanomaterials (Basel). 2023 Nov 24;13(23):3015. doi: 10.3390/nano13233015. Nanomaterials (Basel). 2023. PMID: 38063711 Free PMC article.

4

New Nanoparticle Formulation for Cyclosporin A: In Vitro Assessment.

Gendron A, Lan Linh Tran N, Laloy J, Brusini R, Rachet A, Gobeaux F, Nicolas V, Chaminade P, Abreu S, Desmaële D, Varna M. Gendron A, et al. Among authors: varna m. Pharmaceutics. 2021 Jan 12;13(1):91. doi: 10.3390/pharmaceutics13010091. Pharmaceutics. 2021. PMID: 33445646 Free PMC article.

5

Advanced nanomedicines for the treatment of inflammatory diseases.

Brusini R, Varna M, Couvreur P. Brusini R, et al. Among authors: varna m. Adv Drug Deliv Rev. 2020;157:161-178. doi: 10.1016/j.addr.2020.07.010. Epub 2020 Jul 19. Adv Drug Deliv Rev. 2020. PMID: 32697950 Free PMC article. Review.

6

Squalene-based multidrug nanoparticles for improved mitigation of uncontrolled inflammation in rodents.

Dormont F, Brusini R, Cailleau C, Reynaud F, Peramo A, Gendron A, Mougin J, Gaudin F, Varna M, Couvreur P. Dormont F, et al. Among authors: varna m. Sci Adv. 2020 Jun 5;6(23):eaaz5466. doi: 10.1126/sciadv.aaz5466. eCollection 2020 Jun. Sci Adv. 2020. PMID: 32548259 Free PMC article.

7

Squalene-based nanoparticles for the targeting of atherosclerotic lesions.

Brusini R, Dormont F, Cailleau C, Nicolas V, Peramo A, Varna M, Couvreur P. Brusini R, et al. Among authors: varna m. Int J Pharm. 2020 May 15;581:119282. doi: 10.1016/j.ijpharm.2020.119282. Epub 2020 Apr 4. Int J Pharm. 2020. PMID: 32259640

8

Translation of nanomedicines from lab to industrial scale synthesis: The case of squalene-adenosine nanoparticles.

Dormont F, Rouquette M, Mahatsekake C, Gobeaux F, Peramo A, Brusini R, Calet S, Testard F, Lepetre-Mouelhi S, Desmaële D, Varna M, Couvreur P. Dormont F, et al. Among authors: varna m. J Control Release. 2019 Aug 10;307:302-314. doi: 10.1016/j.jconrel.2019.06.040. Epub 2019 Jun 29. J Control Release. 2019. PMID: 31260754 Free article.

9

Ultrasound-induced mild hyperthermia improves the anticancer efficacy of both Taxol® and paclitaxel-loaded nanocapsules.

Boissenot T, Bordat A, Larrat B, Varna M, Chacun H, Paci A, Poinsignon V, Fattal E, Tsapis N. Boissenot T, et al. Among authors: varna m. J Control Release. 2017 Oct 28;264:219-227. doi: 10.1016/j.jconrel.2017.08.041. Epub 2017 Sep 1. J Control Release. 2017. PMID: 28867377

10

Gold nanoparticles in cardiovascular imaging.

Varna M, Xuan HV, Fort E. Varna M, et al. Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2018 Jan;10(1). doi: 10.1002/wnan.1470. Epub 2017 Apr 6. Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2018. PMID: 28382729 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

40 results

Search Page